|
||
Mave Uses |
||
Irritable bowel syndrome & allied conditions eg, chronic irritable colon, spastic constipation, mucous colitis and spastic colitis. Symptomatic treatment of abdominal pain, cramps, nonspecific diarrhoea & flatulence. GI spasm secondary to organic diseases eg, diverticulitis, gastritis, duodenitis, oesophagitis, cholecystitis, Crohn's disease, ulcerative colitis, peptic ulcer, gallbladder disease, hiatus hernia, GIT inflammation.
Mave is used to treat irritable bowel syndrome (disorder of the intestines that leads to cramps in the abdomen, gas, bloating and changes in bowel habits). It is also used to treat other conditions that involve spasm and pain related to small and large bowel.
Each capsule contains Mebeverine HCl 200 mg.
Mave also contains the following excipients: Capsule Content (Granules): Magnesium stearate, polyacrylate dispersion 30%, talc, hypromellose, methacrylic acid-ethyl acrylate copolymer (1:1) dispersion 30% and glycerol triacetate. Capsule Shell: Gelatin, titanium dioxide (E171). Printing Ink: Shellac (E904), black iron oxide (E172), propylene glycol, concentrated ammonia solution, potassium hydroxide.
Adults: 1 capsule twice daily (1 in the morning and 1 in the evening).
Special Populations: Elderly, Renal and Hepatic Impairment: No posology studies in elderly, renal and/or hepatically impaired patients have been performed. However, no specific risk for elderly, renal and/or hepatically impaired patients could be identified from available post-marketing data. No dosage adjustment is deemed necessary in these patients.
Missed Dose: In case of ≥1 doses missed, continue with the next dose as prescribed; the missed doses are not to be taken in addition to the regular dose.
Administration: The capsules should be swallowed with a sufficient amount of water (at least 100 mL of water).
It should not be chewed because the coating is intended to ensure a prolonged release mechanism.
No interaction studies have been performed except with alcohol. In vitro and in vivo studies in animals have demonstrated the absence of any interaction between Mave and ethanol.
Incompatibilities: Not applicable.
Although adverse effects appear rare, gastrointestinal disturbances, dizziness, headache, insomnia, anorexia and tachycardia have been reported in patients receiving Mave.
Hypersensitivity to Mave HCl or to any of the excipients of Mave.
Mebeverine in Bangladesh.
List of Mave substitutes (brand and generic names) | Sort by popularity |
Unit description / dosage (Manufacturer) | Price, USD |
MATIZ | |
Matiz 30mg TAB / 10 (Gentech HC) | $ 1.61 |
MEB | |
MEB 200 MG CAPSULE SR 1 strip / 10 capsule srs each (Intas Pharmaceuticals Ltd) | $ 1.14 |
Meb 200mg Capsule SR (Intas Pharmaceuticals Ltd) | $ 0.13 |
MEBALFA | |
MEBALFA 10MG TABLET SR 1 strip / 10 tablet srs each (Torrent Pharmaceuticals Ltd) | $ 1.03 |
Mebaspa (India) | |
Mebaspa 135mg TAB / 10 (USV) | $ 0.65 |
135 mg x 10's (USV) | $ 0.65 |
MEBASPA TABLET 1 strip / 10 tablets each (USV) | $ 1.02 |
MEBASPA tab 135 mg x 10's (USV) | $ 0.93 |
Mebaspa 135mg Tablet (USV) | $ 0.10 |
Mebecan | |
Mebecan 200mg Capsule SR (Charan Laboratories Pvt Ltd) | $ 0.20 |
Mebefit (Turkey) | |
Mebemerck (Germany) | |
Mebemint (Colombia) | |
Meberine (Taiwan) | |
Meberine / TTY 135 mg x 500's | |
Meberine / Y.C. 135 mg x 1000's | |
Meberol XR (Ecuador) | |
Mebetin (Malaysia, Singapore) | |
Mebetin 135 mg x 100's (Sam Chun Dang) | |
Mebetin 135 mg x 20 x 10's (Sam Chun Dang) | |
Mebetin tab 135 mg 20 x 10's (Sam Chun Dang) | |
Mebetin tab 135 mg 100's (Sam Chun Dang) | |
Mebever (Taiwan) | |
Mebeverin dura (Germany, Iceland) | |
Mebeverin Puren (Germany) | |
Mebeverin Solvay (Germany) | |
Mebeverine (Argentina, Bahrain, Bangladesh, Belgium, Brazil, Bulgaria, China, Colombia, Czech Republic, Denmark, Estonia, France, Georgia, Greece, Hong Kong, Hungary, Indonesia, Latvia, Lithuania, Malaysia, Mexico, Myanmar, Oman, Peru, Philippines, Poland, Romania, Russian Federation, Singapore, Slovakia, South Korea, Spain, Taiwan, Tunisia, Turkey, Venezuela) | |
Capsule; Oral; Mebeverine Hydrochloride 100 mg | |
Capsule; Oral; Mebeverine Hydrochloride 200 mg | |
Tablet, Sugar-Coated; Oral; Mebeverine Hydrochloride 135 mg | |
Mébévérine | |
Capsule; Oral; Mebeverine Hydrochloride 100 mg | |
Capsule; Oral; Mebeverine Hydrochloride 200 mg | |
Tablet, Sugar-Coated; Oral; Mebeverine Hydrochloride 135 mg | |
Capsule; Oral; Mebeverine Hydrochloride 100 mg | |
Capsule; Oral; Mebeverine Hydrochloride 200 mg | |
Tablet, Sugar-Coated; Oral; Mebeverine Hydrochloride 135 mg | |
Mébévérine Biogaran (France) | |
Mébévérine EG (France) | |
Mebeverine EG (Belgium) | |
Mebeverine EG-135 (Luxembourg) | |
Mebeverine HCl Aurobindo Retard (Netherlands) | |
Mebeverine HCl retard (Netherlands) | |
Mebeverine Hydrochloride Fisher (Netherlands) | |
Mébévérine Qualimed (France) | |
Mebeverine Sopharma (Bulgaria) | |
See 235 substitutes for Mave |
Users | % | ||
---|---|---|---|
Useful | 1 | 100.0% |
Users | % | ||
---|---|---|---|
Expensive | 1 | 100.0% |
Users | % | ||
---|---|---|---|
1 day | 2 | 28.6% | |
> 3 month | 1 | 14.3% | |
2 days | 1 | 14.3% | |
3 month | 1 | 14.3% | |
1 month | 1 | 14.3% | |
3 days | 1 | 14.3% |
Users | % | ||
---|---|---|---|
30-45 | 4 | 57.1% | |
46-60 | 2 | 28.6% | |
> 60 | 1 | 14.3% |
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
|